ID: ALA5189918

Max Phase: Preclinical

Molecular Formula: C19H19FN5Na2O9P

Molecular Weight: 513.38

Associated Items:

Representations

Canonical SMILES:  O=c1ccn([C@@H]2O[C@H](COCc3cn(C(c4ccc(F)cc4)P(=O)([O-])[O-])nn3)[C@@H](O)[C@H]2O)c(=O)[nH]1.[Na+].[Na+]

Standard InChI:  InChI=1S/C19H21FN5O9P.2Na/c20-11-3-1-10(2-4-11)18(35(30,31)32)25-7-12(22-23-25)8-33-9-13-15(27)16(28)17(34-13)24-6-5-14(26)21-19(24)29;;/h1-7,13,15-18,27-28H,8-9H2,(H,21,26,29)(H2,30,31,32);;/q;2*+1/p-2/t13-,15-,16-,17-,18?;;/m1../s1

Standard InChI Key:  NWTDPAOFEJHBAD-SADSOMEESA-L

Associated Targets(Human)

Beta-galactoside alpha-2,6-sialyltransferase 1 179 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 513.38Molecular Weight (Monoisotopic): 513.1061AlogP: -1.17#Rotatable Bonds: 8
Polar Surface Area: 202.02Molecular Species: ACIDHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.33CX Basic pKa: CX LogP: -1.29CX LogD: -3.53
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.23Np Likeness Score: -0.02

References

1. Dobie C, Montgomery AP, Szabo R, Yu H, Skropeta D..  (2021)  Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.,  12  (10.0): [PMID:34778769] [10.1039/D1MD00079A]
2. Dobie C, Montgomery AP, Szabo R, Yu H, Skropeta D..  (2021)  Synthesis and biological evaluation of selective phosphonate-bearing 1,2,3-triazole-linked sialyltransferase inhibitors.,  12  (10.0): [PMID:34778769] [10.1039/D1MD00079A]

Source